• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰宫颈癌发病率和死亡率的趋势:有组织筛查的引入是否有影响?

Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?

机构信息

Second Department of Gynaecological Oncology, St. John's Cancer Centre of Lublin, ul. Jaczewskiego 7, 20-090, Lublin, Poland.

Department of Cancer Prevention, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, ul. Wilhelma Konrada Roentgena 5, 02-781, Warsaw, Poland.

出版信息

Eur J Epidemiol. 2017 Jun;32(6):529-532. doi: 10.1007/s10654-017-0291-6. Epub 2017 Aug 5.

DOI:10.1007/s10654-017-0291-6
PMID:28780640
Abstract

Aside from existing opportunistic screening, an organised screening programme (OSP) for cervical cancer (CC) was implemented in 2006/2007 in Poland. We applied joinpoint regression and age-period-cohort model to look for the impact of the OSP on CC incidence/mortality trends. Decline of age-standardised incidence rates (ASIRs) in the screening-age group (25-59 years) accelerated from -2.2% (95% CI -2.7 to -1.7%) between 1993 and 2008 to -6.1% (95% CI -7.7 to -4.4%) annually after 2008. In women aged 60+ years, ASIRs declined from 1986 until 2005 [annual percent change (APC) = -2.6%, 95% CI -2.9 to -2.4%] and stabilised thereafter. Decline of age-standardised mortality rates (ASMRs) in the screening-age group accelerated from -1.3% (95% CI -1.5 to -1.1%) between 1980 and 2005 to -4.7% (95% CI -5.6 to -3.8%) annually after 2005. In women aged 60+ ASMR declined between 1991 and 2004 (APC = -2.9%, 95% CI -3.5 to -2.3%) and stabilised thereafter. Relative risks of CC diagnosis and death were 0.63 (95% CI 0.62-0.65) and 0.61 (95% CI 0.59-0.63), respectively, for the most recent period compared to the reference around 1982. Implementation of the OSP possibly accelerated downward trends in the burden of CC in Polish women under the age of 60, but recent stabilisation of trends in older women requires actions.

摘要

除了现有的机会性筛查外,波兰于 2006/2007 年实施了一项针对宫颈癌(CC)的有组织筛查计划(OSP)。我们应用联合点回归和年龄-时期-队列模型来研究 OSP 对 CC 发病率/死亡率趋势的影响。筛查年龄组(25-59 岁)的年龄标准化发病率(ASIR)下降速度从 1993 年至 2008 年的-2.2%(95%CI -2.7 至-1.7%)加速至 2008 年后的每年-6.1%(95%CI -7.7 至-4.4%)。60 岁以上女性的 ASIR 从 1986 年下降到 2005 年[每年百分比变化(APC)=-2.6%,95%CI -2.9 至-2.4%],此后稳定下来。筛查年龄组的年龄标准化死亡率(ASMR)下降速度从 1980 年至 2005 年的-1.3%(95%CI -1.5 至-1.1%)加速至 2005 年后的每年-4.7%(95%CI -5.6 至-3.8%)。60 岁以上女性的 ASMR 在 1991 年至 2004 年期间下降(APC=-2.9%,95%CI -3.5 至-2.3%),此后稳定下来。与 1982 年左右的参考期相比,最近时期 CC 诊断和死亡的相对风险分别为 0.63(95%CI 0.62-0.65)和 0.61(95%CI 0.59-0.63)。OSP 的实施可能加速了波兰 60 岁以下女性 CC 负担的下降趋势,但最近老年女性趋势的稳定需要采取行动。

相似文献

1
Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?波兰宫颈癌发病率和死亡率的趋势:有组织筛查的引入是否有影响?
Eur J Epidemiol. 2017 Jun;32(6):529-532. doi: 10.1007/s10654-017-0291-6. Epub 2017 Aug 5.
2
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.波兰有组织的宫颈癌筛查计划的实施:对欧洲指南依从性的分析。
BMC Cancer. 2015 Apr 14;15:279. doi: 10.1186/s12885-015-1242-9.
3
Trends in cervical cancer mortality rates in Lithuania, 1987-2016.1987 - 2016年立陶宛宫颈癌死亡率趋势
Cancer Epidemiol. 2018 Dec;57:85-89. doi: 10.1016/j.canep.2018.10.008. Epub 2018 Oct 19.
4
Impact of the Australian National Cervical Screening Program in women of different ages.澳大利亚国家宫颈癌筛查计划对不同年龄女性的影响。
Med J Aust. 2016 Oct 17;205(8):359-364. doi: 10.5694/mja16.00289.
5
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.评估组织性筛查计划对宫颈癌发病率的影响:来自意大利北部的 26 年研究。
Int J Cancer. 2019 Mar 1;144(5):1017-1026. doi: 10.1002/ijc.31806. Epub 2018 Dec 4.
6
Evaluation of the National Cervical Cancer Screening Programme in Singapore.新加坡国家宫颈癌筛查计划评估。
Singapore Med J. 2013 Feb;54(2):96-101. doi: 10.11622/smedj.2013032.
7
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.芬兰和荷兰的宫颈癌大规模筛查计划及趋势
Int J Cancer. 2008 Apr 15;122(8):1854-8. doi: 10.1002/ijc.23276.
8
The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England.两年与三年一次宫颈筛查间隔推荐对宫颈癌发病率和死亡率的影响:澳大利亚、新西兰和英格兰趋势分析。
Cancer Causes Control. 2013 Sep;24(9):1727-36. doi: 10.1007/s10552-013-0250-9. Epub 2013 Jul 6.
9
Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).苏格兰子宫颈浸润癌的发病率和死亡率趋势(1975 - 1994年)
Public Health. 1998 Nov;112(6):373-8.
10
Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.宫颈癌筛查项目的成效:泰国南部宋卡府1989 - 2010年发病率趋势及至2030年未来发病率预测
Asian Pac J Cancer Prev. 2014;15(22):10003-8. doi: 10.7314/apjcp.2014.15.22.10003.

引用本文的文献

1
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.波兰基于人群的宫颈癌筛查项目中的 HPV 检测(HIPPO 项目)——一项随机医疗政策试验的研究方案。
BMC Cancer. 2023 Nov 17;23(1):1118. doi: 10.1186/s12885-023-11597-5.
2
Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study.格拉纳达人群中与人类乳头瘤病毒相关的肛门生殖器癌症的流行病学:一项长达三十年的基于人群的研究。
Front Public Health. 2023 Sep 14;11:1205170. doi: 10.3389/fpubh.2023.1205170. eCollection 2023.
3
National HPV Vaccination Program in Poland-Public Awareness, Sources of Knowledge, and Willingness to Vaccinate Children against HPV.

本文引用的文献

1
Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.波兰子宫颈病变管理的报销费用——来自国家卫生基金和卫生部数据的描述性分析
Cent Eur J Public Health. 2016 Jun;24(2):163-8. doi: 10.21101/cejph.a4737. Epub 2016 May 13.
2
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.波兰有组织的宫颈癌筛查计划的实施:对欧洲指南依从性的分析。
BMC Cancer. 2015 Apr 14;15:279. doi: 10.1186/s12885-015-1242-9.
3
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
波兰的国家人乳头瘤病毒疫苗接种计划——公众认知、知识来源以及为儿童接种人乳头瘤病毒疫苗的意愿
Vaccines (Basel). 2023 Aug 16;11(8):1371. doi: 10.3390/vaccines11081371.
4
Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.真正的宫颈癌前细胞学阴性报告的原因——波兰宫颈癌筛查计划中细胞学假阴性审核的结果。
Cancer Med. 2023 Jun;12(12):13800-13810. doi: 10.1002/cam4.6024. Epub 2023 May 22.
5
Trends in Musculoskeletal Rehabilitation Needs in China From 1990 to 2030: A Bayesian Age-Period-Cohort Modeling Study.1990 年至 2030 年中国肌肉骨骼康复需求趋势:贝叶斯年龄-时期-队列模型研究。
Front Public Health. 2022 Jun 15;10:869239. doi: 10.3389/fpubh.2022.869239. eCollection 2022.
6
Cervical Cancer Prevention in the Era of the COVID-19 Pandemic.COVID-19 大流行时代的宫颈癌预防。
Medicina (Kaunas). 2022 May 29;58(6):732. doi: 10.3390/medicina58060732.
7
Barriers and attitudes towards cervical cancer screening in primary healthcare in Poland - doctors' perspective.波兰初级医疗保健中宫颈癌筛查的障碍和态度——医生的观点。
BMC Fam Pract. 2021 Dec 30;22(1):260. doi: 10.1186/s12875-021-01612-8.
8
Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening.液基筛查检测结果:基于私立机构的机会性宫颈癌筛查中的人乳头瘤病毒、液基细胞学检查及P16/Ki67双重染色
Diagnostics (Basel). 2021 Aug 5;11(8):1420. doi: 10.3390/diagnostics11081420.
9
The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data.癌症死亡率的社会经济差异中发病率和致死率的各自部分。对法国癌症登记处网络(FRANCIM)数据的分析。
Int J Equity Health. 2019 Dec 3;18(1):189. doi: 10.1186/s12939-019-1087-y.
10
A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.波兰宫颈癌综合防控路线图:将现有解决方案整合到初级和二级预防的当前实践中。
Eur J Cancer Prev. 2020 Mar;29(2):157-164. doi: 10.1097/CEJ.0000000000000528.
全球宫颈癌发病率趋势:筛查对疾病危险因素变化的影响。
Eur J Cancer. 2013 Oct;49(15):3262-73. doi: 10.1016/j.ejca.2013.04.024. Epub 2013 Jun 8.
4
Trends of cervical cancer mortality in the member states of the European Union.欧盟成员国宫颈癌死亡率趋势。
Eur J Cancer. 2009 Oct;45(15):2640-8. doi: 10.1016/j.ejca.2009.07.018. Epub 2009 Aug 18.
5
Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.波兰华沙患宫颈癌和未患宫颈癌女性的人乳头瘤病毒感染情况
Eur J Cancer. 2008 Mar;44(4):557-64. doi: 10.1016/j.ejca.2007.12.001. Epub 2008 Jan 11.
6
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.13个欧洲国家宫颈鳞状细胞癌发病率趋势:风险变化及筛查的影响
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):677-86. doi: 10.1158/1055-9965.EPI-04-0569.
7
The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.大规模筛查对子宫颈鳞状细胞癌和腺癌发病率及死亡率的影响。
Obstet Gynecol. 1995 Jun;85(6):1017-21. doi: 10.1016/0029-7844(95)00063-W.